Evidence is still preliminary, and effects on implantation or IVF outcomes are not established
Somatropin has been FDA-approved since 1985 (recombinant form)
The deeper I dug into the science, the clearer the picture became: menopause is a metabolic tipping point, and hormone decline is not neutral
Retatrutide, an investigational, first-in-class triple hormone receptor agonist (RA), demonstrated positive topline results in the phase 3 TRIUMPH-1 clinical trial ( 1 The 80-week trial evaluated the once-weekly medication in adults with obesity or overweight and at least 1 weight-related comorbidity, but without diabetes
Increased Anxiety and Irritability : Hyperthyroidism can exacerbate feelings of anxiety and lead to a noticeable change in mood or stress levels
Our care is centered around you, offering treatments that fit your wellness goals